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Introduction
As with many chronic diseases, the rate of progression of diabetic nephropathy (DN) depends on the net balance between the severity of the injury and the body's reparative capacity, such that a reduction in injurious stimuli may facilitate regression of disease. There is precedent for this in diabetic kidney disease as tight control of the pre-eminent factors promoting injury, namely hyperglycaemia and hypertension, can result in regression of microalbuminuria 1 .
Furthermore, a reduction in glomerulosclerosis 2 and tubulointerstitial fibrosis 3 has been documented in patients with moderately advanced DN who achieved sustained normoglycaemia following pancreas transplantation. Resolution of fibrosis is, however, a protracted process, requiring up to 10 years of normoglycaemia.
While considerable research has focused on the pathways that promote disease, less is known about mechanisms of repair. This is partly due to the scarcity of kidney tissue available from patients during regression of DN, as there is little rationale for performing renal biopsy in this setting. Furthermore, the regression has been difficult to study in an experimental setting as traditional animal models exhibit only the earliest features of human disease 4 .
We recently described a rodent model in which hyperglycaemic and renin-dependent hypertension synergise to promote transcriptomic and pathological changes typical of moderately advanced human DN 5 . An attractive feature of this model is that the Cyp1a1mRen2 rats have a copy of the murine ren2 cDNA integrated into their genome under the control of the Cyp1a1 promoter, such that the severity of hypertension can be regulated by altering the dietary concentration of indole-3-carbinol (I-3-C) 6 .
The aim of the current study was to identify pathways that were differentially regulated in the kidney during and following reversal of hyperglycaemia and hypertension in the Cyp1a1mRen2 model using systematic gene expression profiling.
Accepted Article

Materials and methods
Animal studies
Diabetes was induced in adult, male Cyp1a1mRen2 Fisher rats with an intravenous bolus of 20mg/kg streptozotocin and confirmed by blood glucose >15mM three days later. Thereafter, blood glucose was maintained between 20-30mM with serial subcutaneous insulin implants (Research Pack, Linshin, Canada). Two weeks after streptozotocin, 0.125% I-3-C (Sigma, UK) was added to the diet to maintain tail-cuff systolic BP at approximately 200mmHg. At the end of the 28wk 'injury phase' the animals were randomised into two groups matched for blood glucose, blood pressure and albuminuria. An injury cohort (n=10) was culled immediately, while in a reversal cohort (n=9) the blood glucose concentration was tightly controlled by increasing the frequency/dose of the insulin implants and I-3-C was removed from the diet to facilitate normalisation of blood pressure for a further eight weeks ( Fig 1A) .
Six age-matched, male, non-diabetic, non-hypertensive controls were culled at 28wks.
Procedures were performed under UK Home Office licence following approval by the Ethics Committee, University of Edinburgh.
Quantification of proteinuria and renal function
24hr urine collections were obtained at baseline, 9, 18 and 28wks and at 1, 2, 4, 6 and 8wks after reversal. Tail vein blood samples were taken at baseline, after 28 weeks of injury and eight weeks of reversal. Albumin and creatinine measurements were performed on a Cobas Fara centrifugal analyser (Roche Diagnostics Ltd, UK) using a commercial immunoturbidimetric assay (Microalbumin Kit, Olympus Diagnostics Ltd, Watford, UK) and a creatininase-based enzymatic method (Alpha Laboratories Ltd, Eastleigh, UK), respectively.
Immunohistochemistry
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Immunohistochemistry was performed using standard protocols on 4M methacarn-fixed 
Gene expression analysis
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RNA was extracted (Nucleospin RNAII kit, Macherey-Nagel, Duren, Germany) from snapfrozen, homogenised renal cortices from representative animals from the injury cohort (n=8), the reversal cohort (n=4) and from controls (n=4) and hybridized to the Affymetrix Rat 
Metalloproteinase activity assay/zymography
For the MMP activity assay/zymography, frozen renal cortex was homogenised (20%v/w) in RIPA lysis buffer or 150mM NaCl/1% Triton X-100/50mM Tris, respectively, and normalised for protein concentration (BCA assay, Thermo Scientific, Northumberland, UK).
Metalloproteinase activity was assessed using the EnzChek Gelatinase/Collagenase Assay Kit (Invitrogen) employing the gelatinase/collagenase inhibitor 1,10-phenanthroline, monohydrate as a negative control.
For substrate zymography polyacrylamide gels were co-polymerized with either gelatin (1mg/ml) or collagen (0.2mg/ml) and 100µg lysate per lane was separated by electrophoresis.
Gels were washed twice with 2.5% Triton X-100, incubated at 37°C for 48-72 hours (Bio- 
Western blotting
Renal cortices were homogenised in 150 mM NaCl/20 mM Tris-HCl/1mM EDTA (pH8)/1%
Triton-X 100/protease inhibitor cocktail (Roche, Switzerland). 30 μg protein was separated on a 10% SDS gel, transferred to a membrane and incubated with rabbit anti-rat TIMP-1 antibody (1: 1000, Biorbyt, Cambridge, UK) or rabbit anti-rat β-actin (1 : 1000, Abcam, Cambridge, UK) and horseradish peroxidase-conjugated anti-rabbit IgG secondary (1 : 2,000, Dako, Hamburg, Germany). Recombinant TIMP1 (RayBiotech, Norcross, USA) constituted a positive control. Blots were developed using a chemiluminescence kit (ECL Plus, Amersham, GE Healthcare, Buckinghamshire, UK), imaged on a Versadoc system (Bio-Rad, Hercules, USA) and densitometry was performed using Adobe Photoshop Software.
Statistical analysis
Data are means (±SEM) and medians (IQR) where normal or skewed, respectively. Groups were compared by 1-way ANOVA followed by Bonferroni corrections (following logtransformation of non-parametric data). The Benjamini-Hochberg false-discovery rate method was used to correct for multiple testing in microarray analysis.
Results
Biochemical parameters
During the 28wk injury phase, there was a progressive rise in albuminuria (Fig 1B-D) . In the reversal cohort, an increase in the dose and frequency of subcutaneous insulin implants ameliorated hyperglycaemia ( Fig 1B) while removal of 1-3-C from the diet normalised systolic blood pressure ( Fig 1C) . This led to a rapid initial reduction in albuminuria probably related to haemodynamic factors followed by a more gradual decline, though it remained Accepted Article persistently greater than in controls ( Fig 1D) . After 28wks of diabetes and hypertension, creatinine clearance was not significantly different in either the injury (2.45±0.87ml/min) or reversal cohorts (2.46±0.30ml/min) compared with controls (2.37±0.63ml/min, p=0.48 and p=0.64, respectively) and remained unchanged following 8wks of relative normalisation of glycaemia and blood pressure (2.59±0.63ml/min, p=0.56 v peak injury).
Pathological parameters
The mean percentage kidney:body weight ratio increased in the injury cohort compared with controls (0.47±0.06 v 0.30±0.01, p<0.001, Table 1 ). This reduced in the reversal cohort (0.36±0.03, p<0.001 v injury cohort) though it remained significantly (p<0.05) greater than in controls. There was a marked increase in the glomerulosclerosis and tubulointerstitial fibrosis indices in the injury cohort compared with controls ( Fig 2) . After 8wks of tight blood glucose and blood pressure control, the reversal cohort exhibited similar severity of glomerulosclerosis and tubulointerstitial fibrosis to the injury cohort, and significantly greater levels than controls (Fig 2) . There were no differences between the groups in the mean hilar glomerular cross-sectional area or mean number of glomeruli per tissue section (Table 1) .
While there was a trend towards a reduction in the mean number of WT1 + podocytes/hilar glomerular cross-sectional in the injury and reversal cohorts compared with control animals, this did not reach statistical significance (p=0.07, Suppl Figure) .
Microarray data
To identify pathways activated in the kidney during and following reversal of hyperglycaemia and hypertension, we compared gene expression patterns in the renal cortices of the injury and reversal cohorts with controls. 677 genes were up-regulated >1. Table 2 ).
145 genes were down-regulated >50% in the injury cohort compared with controls (corrected p<0.01). The expression of 80 of these 145 genes did not increase significantly (<20% increase compared to peak injury) after 8wks of reversal of hyperglycaemia and hypertension and were designated as 'persistently repressed' (Figure 3 and Suppl Table 3 ). Conversely, there was a significant (corrected p<0.05) increase in the expression of 4 of the 145 downregulated genes (Von Willebrand factor, phospholipase A2 group 6, malic enzyme 1, and lactate dehydrogenase D), such that they were no longer differentially expressed compared to controls (designated 'de-repressed' Fig 3) .
Finally, the expression of a small number of genes did not change during injury but was significantly (corrected p<0.05) down-regulated (n=19) or up-regulated (n=5) after 8wks of reversal of hyperglycaemia or hypertension (Fig 3, Suppl Table 4 ). Remarkably, 12/19 genes (63%) that were down-regulated specifically during reversal encoded for proteins selectively expressed on endothelial cells.
Validation of microarray findings
Pathway analysis using both Ingenuity and Metacore (Table 2 ) determined that many of the genes that were up-regulated specifically during injury are implicated in acute phase response, complement/coagulation pathways and regulation of the ECM. The pattern of expression of selected ECM-related genes was validated by real-time PCR (Fig 4A) .
Amongst the genes whose expression remained persistently up-regulated during reversal there was an over-representation of genes implicated in innate and adaptive immunity, ECM degradation, Wnt pathway and apoptosis (Table 3) . Consistent with the transcriptomic data, increased numbers of macrophages were found in both the injury and reversal cohorts (Fig   4Bi) , however there was a switch in macrophage phenotype, with increased classically activated iNOS + macrophage infiltration occurring exclusively during injury (Fig 4Bii) , Accepted Article whereas infiltrates of mannose receptor (MR) + macrophages were observed both during and following reversal of injury (Fig 4Biii) . T-cells infiltrated the interstitium of both the injury and repair cohorts (Fig 4Ci) and interestingly, there was persistent increase in expression of the foxp3 gene, a marker of regulatory T-cells (T Reg ) (Fig 4Cii) .
Metalloproteinase activity assays
Real-time PCR confirmed that the expression of multiple matrix metalloproteinase (MMP) genes was increased during injury, with mmp-7 and -12 remaining up-regulated or even increasing during reversal, while mmp-2, and -14 partially reverted towards control levels ( Fig 5A) . Despite the increase in MMP gene expression, there was a paradoxical decrease in MMP activity in the renal cortex during both injury and reversal as assessed by gelatinase and collagenase activity assays (Fig 5B) . Gene expression of tissue inhibitor of metalloproteinase-1 (timp-1), and to a lesser extent timp-2, increased during injury (Fig 5Ci) , and while expression of the timp-1 gene fell significantly during reversal, TIMP-1 protein remained persistently elevated compared to controls (Fig 5Cii) . In contrast to the reduced MMP activity in whole kidney lysates, when TIMPs were physically separated from the MMPs during gel zymography, MMP-2 (72kD band in gelatinase zymogram, Fig 5Di) and MMP-1 (52kD band in collagenase zymogram, Fig 5Dii) activity in both the injury and reversal cohorts tended to be greater than in controls, and indeed MMP-1 activity was significantly greater during reversal than in controls.
Discussion
In our rodent model of moderately advanced DN, relative normalisation of hyperglycaemia and hypertension for eight weeks reduced albuminuria and renal hypertrophy but did not lead to regression of established renal scarring. This is in contrast to previous studies in which scar regression was observed after a similar duration of tight glycaemic control or reninangiotensin system blockade, however these studies were performed in non-diabetic models 8 9 or in models of early diabetic injury 10 . The current findings must be considered in the context of human disease, where regression of fibrosis in the diabetic kidney is a protracted process, requiring ten years of normoglycaemia following pancreatic transplantation, with no improvement documented after five years 2 .
There is scant data regarding how the diabetic kidney responds to a period of tight blood glucose and blood pressure control. The patterns of gene expression in the kidney of diabetic and hypertensive Cyp1a1mRen2 rats have been shown to closely reflect those in human disease 5 , therefore we considered it an appropriate model in which to dissect the pathways activated in the kidney during and following reversal of hyperglycaemia and hypertension.
Our study provides insight into the mechanisms that promote fibrosis and a rationale as to why the diabetic kidney is so resistant to repair.
The 85 genes that were up-regulated specifically during the injury phase were markedly enriched for genes encoding ECM proteins, suggesting that tight blood glucose and blood pressure control was sufficient to switch off excess ECM production and prevent progression of fibrosis. Within this group were multiple myofibroblast markers including transgelin, platelet-derived growth factor-β and -smooth muscle actin, which is consistent with the role of the myofibroblast as the chief scar-producing cell in the kidney 11 . We hypothesise that many of the other genes that are similarly up-regulated specifically during the injury phase (Suppl table 1 ) may also be implicated in the pro-fibrotic response, and evidence from fibrosis in other organs supports this concept. The lysyl oxidase and lysyl oxidase-like 2 genes are both up-regulated in liver and lung fibrosis, where they mediate collagen crosslinkage, rendering it resistant to degradation. 12 Similarly, the cadherin 11 gene is up-regulated in idiopathic pulmonary fibrosis with administration of a neutralising antibody against CDH11 proving beneficial in experimental lung fibrosis 13 . In addition, pathway analysis of genes up-regulated during the injury phase demonstrated enrichment with acute phase Accepted Article response and complement genes, which are classically associated with acute renal injury, but have been recently recognised to be activated in human DN 14 .
We observed a much larger group of genes that remain up-regulated despite tight blood glucose and blood pressure control. We hypothesise that these may constitute a thwarted attempt at repair, remaining persistently up-regulated in a bid to restore normal tissue homeostasis. Prominent amongst these persistently up-regulated genes are those linked to innate and adaptive immunity. T-cell infiltration has been documented in the kidneys of patients with DN 15 , however their role is uncertain as they may promote albuminuria 16 Ephrin, and Nrf2 signalling pathways were over-represented amongst genes that remained up-regulated despite reversal of diabetes and hypertension, which is of interest, given that all these pathways have been associated with repair in other models of renal injury [21] [22] [23] . Taken together, the switch in macrophage polarisation and pathway analysis suggests attempts at repair are initiated, however we cannot exclude the possibility that some of the gene Accepted Article expression changes are due to residual injury due to modest hyperglycaemia or ongoing albuminuria.
Our study offers insight as to why the reparative pathways that are initiated in the diabetic kidney are relatively ineffectual in degrading excess ECM. Despite a marked increase in MMP gene expression, the MMP activity was reduced to a comparable level to that observed following addition of a biochemical inhibitor of MMP activity. This suggests that an endogenous inhibitor of MMPs may be present, and a likely candidate is TIMP-1 protein, which is persistently expressed in both injury and reversal phases. Furthermore, the noncovalent nature of the TIMP:MMP interaction facilitated physical separation of the TIMPs from MMPs during gel zymography, and under these conditions the activity of both a collagenase, MMP-1, and a gelatinase, MMP-2, increased substantially. TIMP-1 is also upregulated in human diabetic nephropathy 24 and strategies to block the action of TIMP-1 in vivo, thereby facilitating the ECM-degrading activity of the up-regulated MMPs, may be an attractive therapeutic target in DN. While this strategy has proven beneficial in rodent models of cirrhosis 25 , the role of MMPs and TIMPs in renal fibrosis is complex as MMPs may also exert detrimental effects by activating multiple pro-inflammatory pathways, therefore the efficacy and safety of TIMP-1 antagonism must be confirmed initially in rodent studies.
In our microarray profiling we identified that the majority of the 145 genes which were down-regulated in the injury cohort continued to be expressed at reduced levels during reversal. While this may reflect an important functional transcriptomic response of surviving nephrons to injury, it is perhaps more likely that it simply reflects a loss of nephron mass as this subset included structural genes, such as nephrin. Consistent with this hypothesis, there was a trend towards a persistent reduction in the number of WT1+ cells/glomerular crosssection, suggesting that tight glycaemic and blood pressure control was insufficient to restore nephron mass, and that additional therapies may be required to promote regeneration of nephrons. Interestingly, more than half of the genes that were specifically down-regulated Accepted Article during reversal are found relatively selectively on endothelial cells. The significance of this is uncertain and will be the focus of further investigation.
We acknowledge that our study has several limitations. As we reversed both hyperglycaemia and hypertension simultaneously, we cannot determine which of these factors was primarily responsible for the findings observed during reversal. Furthermore, our ability to rapidly switch off the mRen2 transgene, enabled blood pressure to be almost normalised, which is not always achieved in patients with DN. However, we considered that with suboptimal blood pressure control or removal of single injurious stimulus, the presence of on-going injury would preclude identification of pathways that promoted repair. Similarly, the study was not designed to differentiate between the effects of a reduction in blood pressure versus de-activation of the renin-angiotensin system per se. While the period of blood glucose and blood pressure control was of similar duration to that employed in other rodent studies [7] [8] [9] [10] , in this more advanced model of DN it may be that a longer period is required for regression to occur, as in human disease 2 . Finally, an additional cohort of animals that were maintained diabetic and hypertensive throughout the 36 week period would have been helpful in determining whether the reduction in expression of pro-fibrotic genes observed during the reversal phase was sufficient to prevent further progression of DN, however this was not the primary focus of the current study. Furthermore, the reversal cohort at 36wks was compared with the control and injury groups at 28wks, therefore it is possible that the reversal group Accepted Article Cell adhesion: platelet-endothelium-leucocyte interactions 3.94x10 -7 Cell adhesion: integrin-mediated cell-matrix interactions 1.99x10 -5 Development: regulation of epithelial-to-mesenchymal transition 2.24x10 -4 Cell adhesion: glycoconjugates 6.94x10 -4 Ingenuity Pathway Analysis Hepatic fibrosis/Hepatic stellate cell activation 9.55x10 -7 Complement system 2.19x10 -6 Acute phase response signalling 1.74x10 -5 Intrinsic prothrombin activation pathway 5.62x10 -5 Agranulocyte adhesion and diapedesis 5.50x10 -4 Role of pattern recognition receptors in recognition of bacteria and viruses 8.51x10 -4 Coagulation system 1.66x10 -3 Glioma invasiveness signalling 5.50x10 -3 Cell cycle: G2/M DNA damage checkpoint regulation 5.50x10 -3 Role with control rats we identified that: 85 genes were up-regulated specifically during injury and reverted towards control levels in the reversal cohort; 314 genes remained persistently upregulated despite relative normalisation of blood glucose and blood pressure; 80 genes were persistently repressed during both injury and repair; four genes were down-regulated during injury, but returned towards normal levels following normalisation of blood glucose and blood pressure; 19 and five genes were not differentially expressed during injury, but were down-or up-regulated, respectively, during reversal.
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Figure 5B 
